首页> 外文期刊>Nature >Genetics, pathogenesis and clinical interventions in type 1 diabetes
【24h】

Genetics, pathogenesis and clinical interventions in type 1 diabetes

机译:1型糖尿病的遗传,发病机制和临床干预

获取原文
获取原文并翻译 | 示例
           

摘要

Type 1 diabetes is an autoimmune disorder afflicting millions of people worldwide. Once diagnosed, patients require lifelong insulin treatment and can experience numerous disease-associated complications. The last decade has seen tremendous advances in elucidating the causes and treatment of the disease based on extensive research both in rodent models of spontaneous diabetes and in humans. Integrating these advances has led to the recognition that the balance between regulatory and effector T cells determines disease risk, timing of disease activation, and disease tempo. Here we describe current progress, the challenges ahead and the new interventions that are being tested to address the unmet need for preventative or curative therapies.
机译:1型糖尿病是一种自身免疫性疾病,困扰着全球数百万人。一旦被诊断,患者需要终生胰岛素治疗,并可能经历许多与疾病相关的并发症。在过去十年中,基于对自发性糖尿病的啮齿动物模型和人类的广泛研究,在阐明疾病的原因和治疗方法方面取得了巨大的进步。整合这些进展已使人们认识到,调节性T细胞和效应T细胞之间的平衡决定了疾病风险,疾病激活时机和疾病节奏。在这里,我们描述了当前的进展,面临的挑战以及正在测试中的新干预措施,以解决预防或治愈疗法的未满足需求。

著录项

  • 来源
    《Nature》 |2010年第7293期|p.1293-1300|共8页
  • 作者单位

    Diabetes Center and the Department of Medicine, University of California, San Francisco, San Francisco, California 94143, USA;

    Department of Immunobiology, Yale University, New Haven, Connecticut 06520, USA;

    Barbara Davis Center for Childhood Diabetes, University of Colorado, Aurora, Colorado 80045-6511, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号